Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study

R.D. Ting, A.C. Keech, P.L. Drury, M.W. Donoghoe, J. Hedley, A.J. Jenkins, Timothy Davis, S. Lehto, D. Celermajer, R.J. Simes, K. Rajamani, K. Stanton

    Research output: Contribution to journalArticle

    75 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)218-225
    JournalDiabetes Care
    Volume35
    Issue number2
    DOIs
    Publication statusPublished - 2012

    Cite this

    Ting, R. D., Keech, A. C., Drury, P. L., Donoghoe, M. W., Hedley, J., Jenkins, A. J., Davis, T., Lehto, S., Celermajer, D., Simes, R. J., Rajamani, K., & Stanton, K. (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment: The FIELD Study. Diabetes Care, 35(2), 218-225. https://doi.org/10.2337/dc11-1109